Premenstrual syndrome (PMS) is any of a complex of symptoms experienced by some women in the days immediately before menstruation
Aetiology
The vast majority of women (95%) get premenstrual symptoms, however to be classed as PMS the symptoms must impact on daily living
Four in ten women (40%) experience symptoms of PMS and of these 5–8% suffer from severe PMS
Pathophysiology
Not clearly understood
Sensitivity to progesterone - serum concentrations of estrogen and progesterone the same in those with and without PMS
Serotonin receptors are responsive to estrogen and progesterone, and selective serotonin reuptake inhibitors (SSRIs) are proven to reduce PMS symptoms
GABA (γ-aminobutyric acid) levels are modulated by the metabolite of progesterone, allopregnanolone, and in women with PMS the allopregnanolone levels appear to be reduced
Clinical presentation
Symptoms must be present in luteal phase, abate during menstruation followed by a symptom free week
Physical symptoms
Breast tenderness
Bloating
Headache
Skin disorder
Weight gain
Swelling
Joint pain
Fatigue
Psychological symptoms
Mood swings
Anger
Depression
Tension
Not in control
Lack of interest
Loneliness
Hopelessness
Suicidal ideation
Behavioural symptoms
Sleep disturbance
Change in appetite
Restlessness
Poor concentration
Confusion
Social withdrawal
Investigations
Record symptoms prospectively, over two cycles using a symptom diary (retrospective recall unreliable)
A symptom diary should be completed by the patient prior to commencing treatment
Can use GnRH analogues to help if diagnosis from diary no conclusive